GSKCONS

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that Board of Directors at its meeting held on May 10, 2019, recommended Final Dividend of Rs. 105 per equity share.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 11, 2018 the Board also recommended a Dividend at the rate of Rs. 75/-per equity share of Rs. 10 each.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Date of payment of dividend

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 11, 2017, the Board also recommended a Dividend at the rate of Rs. 70/- per equity share of Rs. 10 each. The Dividend, if approved by the shareholders in the ensuing Annual General Meeting scheduled to be held on August 9, 2017, will be paid to those members whose names appear in the Company's Register of Members and to those persons whose names appear as Beneficial owners as per the details to be furnished by National Securities Depository Limited and Cen

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on May 17, 2016 has recommended a Dividend at the rate of Rs. 70/- per equity share of Rs. 10 each. The Dividend, if approved by the shareholders in the ensuing Annual General Meeting scheduled to be held on August 5, 2016, will be paid to those members whose names appear in the Company's Register of Members and to those persons whose names appear as Beneficial owners as per the details to be furnished by National Securities Depository Limited and Central Depos

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Board recommended a Dividend at the rate of Rs. 55/- per equity share of Rs. 10 each.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the dividend shall be paid to the entitled Members on or before September 5, 2015.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 09, 2014,has recommended a Dividend at the rate of Rs. 45/- per equity share of Rs. 10 each. The dividend shall be paid to the entitled Members on or before September 05, 2014.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 15, 2013, inter alia, has recommended a Dividend at the rate of Rs. 45 per equity share of Rs. 10 each.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the dividend shall be paid to the entitled Members on or before May 08, 2013.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the dividend shall be paid to the entitled Members on or before April 03, 2012.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 06, 2012 has recommended a Dividend at the rate of Rs. 35/- per equity share of Rs. 10 each.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 02, 2011 has recommended a Dividend at the rate of Rs. 50 per equity share of Rs.10 each (Dividend of Rs. 25 per equity share and a Special Dividend of Rs. 25 per equity share to celebrate Golden Jubilee of the Company).

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on January 25, 2010 has recommended a Final Dividend at the rate of Rs.18 per equity share of Rs.10 each. Further, the Annual General Meeting is scheduled to be held on April 23, 2010. Further, the Register of Members and Share Transfer Books will remain closed from April 13, 2010 to April 23, 2010, both days inclusive, for the purpose of Dividend and Annual General Meeting.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on January 27, 2009 has recommended a Final Dividend of Rs. 5/- per equity share of Rs. 10/- each for the year ended December 31, 2008.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on October 24, 2008 has declared an interim dividend of Rs.10/- per equity share for the year ending December 31, 2008 and has fixed October 31, 2008 as the record date for this purpose. Dividend warrants in respect to the proposed dividend will be made payable on or before November 18, 2008.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board has declared an interim dividend of Rs.12.00 per equity share for the year ending December 31, 2007.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors in its meeting held on October 26, 2006 has declared an interim dividend of Rs.10/- per equity share for the year ending December 31, 2006.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the board in its meeting held on October 21, 2005 has declared an interim dividend of Rs.8.00 per equity share for the year ending December 31, 2005.Dividend warrants in respect of the proposed dividend will be made payable on or before November 18, 2005.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board has, at its meeting held on October 25, 2004, declared a second interim dividend of Rs.3.70 per equity share for the year ending December 31, 2004 and the dividend warrants in respect of the proposed dividend will be made payable on or before November 22, 2004.